| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |